Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 4
2018 9
2019 5
2020 8
2021 9
2022 7
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yannick le bras[Author] (1 results)?
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Duployez N, Largeaud L, Duchmann M, Kim R, Rieunier J, Lambert J, Bidet A, Larcher L, Lemoine J, Delhommeau F, Hirsch P, Fenwarth L, Kosmider O, Decroocq J, Bouvier A, Le Bris Y, Ochmann M, Santagostino A, Adès L, Fenaux P, Thomas X, Micol JB, Gardin C, Itzykson R, Soulier J, Clappier E, Recher C, Preudhomme C, Pigneux A, Dombret H, Delabesse E, Sébert M. Duployez N, et al. Among authors: le bris y. Blood. 2022 Aug 18;140(7):756-768. doi: 10.1182/blood.2021015328. Blood. 2022. PMID: 35443031 Free PMC article.
Susceptibility to mycobacterial infection in VEXAS syndrome.
Riescher S, Lecomte R, Danic G, Graveleau J, Le Bris Y, Hello M, Guillouzouic A, Guardiolle V, Garnier A, Grossi O, Gaborit B, Néel A. Riescher S, et al. Among authors: le bris y. Rheumatology (Oxford). 2024 Feb 5:keae087. doi: 10.1093/rheumatology/keae087. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38317027
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.
Tamburini J, Mouche S, Larrue C, Duployez N, Bidet A, Salotti A, Hirsch P, Rigolot L, Carras S, Templé M, Favale F, Flandrin-Gresta P, Le Bris Y, Alary AS, Mauvieux L, Tondeur S, Delabesse E, Delhommeau F, Sujobert P, Kosmider O. Tamburini J, et al. Among authors: le bris y. Blood Adv. 2023 Dec 26;7(24):7576-7580. doi: 10.1182/bloodadvances.2023011916. Blood Adv. 2023. PMID: 37987760 Free PMC article. No abstract available.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Decombis S, Bellanger C, Le Bris Y, Madiot C, Jardine J, Santos JC, Boulet D, Dousset C, Menard A, Kervoelen C, Douillard E, Moreau P, Minvielle S, Moreau-Aubry A, Tessoulin B, Roue G, Bidère N, Le Gouill S, Pellat-Deceunynck C, Chiron D. Decombis S, et al. Among authors: le bris y. Blood. 2023 Nov 2;142(18):1543-1555. doi: 10.1182/blood.2023020211. Blood. 2023. PMID: 37562004
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies.
Sujobert P, Le Bris Y, de Leval L, Gros A, Merlio JP, Pastoret C, Huet S, Sarkozy C, Davi F, Callanan M, Thieblemont C, Sibon D, Asnafi V, Preudhomme C, Gaulard P, Jardin F, Salles G, Macintyre E. Sujobert P, et al. Among authors: le bris y. Hemasphere. 2018 Dec 27;3(1):e169. doi: 10.1097/HS9.0000000000000169. eCollection 2019 Feb. Hemasphere. 2018. PMID: 31723808 Free PMC article.
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.
Simonin M, Andrieu GP, Birsen R, Balsat M, Hypolite G, Courtois L, Graux C, Grardel N, Cayuela JM, Huguet F, Chalandon Y, Le Bris Y, Macintyre E, Gandemer V, Petit A, Rousselot P, Baruchel A, Bouscary D, Hermine O, Boissel N, Asnafi V. Simonin M, et al. Among authors: le bris y. Blood. 2023 Mar 16;141(11):1353-1358. doi: 10.1182/blood.2022017755. Blood. 2023. PMID: 36599110 Free article. No abstract available.
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
Peterlin P, Le Bris Y, Turlure P, Chevallier P, Ménard A, Gourin MP, Dumas PY, Thepot S, Berceanu A, Park S, Hospital MA, Cluzeau T, Bouzy S, Torregrosa-Diaz JM, Drevon L, Sapena R, Chermat F, Ades L, Dimicoli-Salazar S, Chevret S, Béné MC, Fenaux P. Peterlin P, et al. Among authors: le bris y. Lancet Haematol. 2023 Jul;10(7):e521-e529. doi: 10.1016/S2352-3026(23)00090-X. Epub 2023 May 25. Lancet Haematol. 2023. PMID: 37245522 Clinical Trial.
Good IgA Bad IgG in SARS-CoV-2 Infection?
Béné MC, de Carvalho Bittencourt M, Eveillard M, Le Bris Y. Béné MC, et al. Among authors: le bris y. Clin Infect Dis. 2020 Jul 28;71(15):897-898. doi: 10.1093/cid/ciaa426. Clin Infect Dis. 2020. PMID: 32280952 Free PMC article. No abstract available.
Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial.
Peterlin P, Garnier A, Le Bourgeois A, Guillaume T, Le Bris Y, Theisen O, Béné MC, Eveillard M, Rimbert M, Jullien M, Planche L, Gaschet J, Chevallier P. Peterlin P, et al. Among authors: le bris y. EClinicalMedicine. 2023 Sep 28;64:102254. doi: 10.1016/j.eclinm.2023.102254. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37786451 Free PMC article.
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.
Dulucq S, Hayette S, Cayuela JM, Bauduer F, Chabane K, Chevallier P, Cony-Makhoul P, Flandrin-Gresta P, Jeune CL, Bris YL, Legros L, Maisonneuve H, Roy L, Mahon FX, Sloma I, Rea D, Nicolini FE. Dulucq S, et al. Among authors: bris yl. Haematologica. 2022 Dec 1;107(12):2944-2949. doi: 10.3324/haematol.2022.280740. Haematologica. 2022. PMID: 35924576 Free PMC article. No abstract available.
46 results